Working… Menu
Trial record 2 of 2 for:    Aradigm Corporation | Phase 3

Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01515007
Recruitment Status : Completed
First Posted : January 23, 2012
Last Update Posted : March 26, 2021
Grifols Therapeutics LLC
Information provided by (Responsible Party):
Savara Inc. ( Aradigm Corporation )